The global CRISPR-based gene editing market size was estimated at USD 4.01 billion in 2024 and is projected to reach USD 13.50 billion by 2033, growing at a CAGR of 14.7% from 2025 to 2033. This growth is driven by the rising prevalence of genetic disorders, advancements in research and technology, supportive government initiatives, and increasing investment in biotechnology.
These advancements also expand CRISPR into new application areas beyond human therapeutics, including agriculture, industrial biotechnology, diagnostics, and environmental management. In agriculture, CRISPR is being applied to create climate-resilient, pest-resistant, and nutrient-enhanced crops, offering solutions to food security challenges. In diagnostics, CRISPR-based tools such as SHERLOCK and FELUDA enable rapid, low-cost detection of infectious diseases. At the same time, in synthetic biology, CRISPR is used to engineer microorganisms for sustainable biofuel and material production. The widening scope of CRISPR applications, coupled with ongoing technical refinements, is attracting strong investments from pharmaceutical companies, agri-biotech firms, and research institutions. This continual innovation cycle expands the addressable market and strengthens CRISPR’s position as a transformative technology platform across multiple industries.
This product will be delivered within 2 business days.
Advancements in CRISPR Technology & Applications
Advancements in CRISPR technology and applications are significantly accelerating market growth by enhancing precision, efficiency, and versatility in gene editing. Since its discovery, the CRISPR-Cas system has evolved beyond basic DNA cutting into a sophisticated genome engineering platform. It is supported by innovations such as high-fidelity Cas variants, base editing, prime editing, and improved delivery mechanisms such as lipid nanoparticles and viral vectors. These improvements have reduced off-target effects, increased editing efficiency, and broadened the scope of treatable conditions. Integration with artificial intelligence (AI) and machine learning has further optimized guide RNA design and target site selection, enabling faster, more accurate development cycles. Technology’s adaptability also supports multiplexed editing, allowing simultaneous modification of multiple genes crucial for tackling complex diseases and traits.These advancements also expand CRISPR into new application areas beyond human therapeutics, including agriculture, industrial biotechnology, diagnostics, and environmental management. In agriculture, CRISPR is being applied to create climate-resilient, pest-resistant, and nutrient-enhanced crops, offering solutions to food security challenges. In diagnostics, CRISPR-based tools such as SHERLOCK and FELUDA enable rapid, low-cost detection of infectious diseases. At the same time, in synthetic biology, CRISPR is used to engineer microorganisms for sustainable biofuel and material production. The widening scope of CRISPR applications, coupled with ongoing technical refinements, is attracting strong investments from pharmaceutical companies, agri-biotech firms, and research institutions. This continual innovation cycle expands the addressable market and strengthens CRISPR’s position as a transformative technology platform across multiple industries.
Global CRISPR-based Gene Editing Market Report Segmentation
This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. The analyst has segmented the global CRISPR-based gene editing market based on product & service, application, end use, and region:Product & Service Outlook (Revenue, USD Million, 2021-2033)
- Products
- CRISPR Kits & Reagents
- CRISPR Libraries
- Others
- Services
Application Outlook (Revenue, USD Million, 2021-2033)
- Biomedical
- Therapeutic Development
- By Indication
- Genetic Disorders
- Oncology
- Ophthalmology
- Others
- By Delivery Method
- Ex Vivo
- In Vivo
- Disease Diagnostics
- Agricultural applications
- Plant Engineering
- Farm Animals Engineering
- Others
End Use Outlook (Revenue, USD Million, 2021-2033)
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Contract Research Organizations
Regional Outlook (Revenue, USD Million, 2021-2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
- Latin America
- Brazil
- Argentina
- MEA
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the industry across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segmental and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
This product will be delivered within 2 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. CRISPR-based Gene Editing Market Variables, Trends & Scope
Chapter 4. CRISPR-based Gene Editing Market: Product & Service Estimates & Trend Analysis
Chapter 5. CRISPR-based Gene Editing Market: Application Estimates & Trend Analysis
Chapter 6. CRISPR-based Gene Editing Market: End Use Estimates & Trend Analysis
Chapter 7. CRISPR-based Gene Editing Market: Regional Estimates & Trend Analysis
Chapter 8. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
The major companies profiled in this CRISPR-based Gene Editing market report include:- Revvity, Inc.
- Danaher
- GenScript
- Merck KGaA
- Thermo Fisher Scientific, Inc.
- Tocris Bioscience
- OriGene Technologies, Inc.
- Bio-Rad Laboratories
- Bio-Techne
- New England Biolabs, Inc.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 120 |
Published | August 2025 |
Forecast Period | 2024 - 2033 |
Estimated Market Value ( USD | $ 4.01 Billion |
Forecasted Market Value ( USD | $ 13.5 Billion |
Compound Annual Growth Rate | 14.7% |
Regions Covered | Global |
No. of Companies Mentioned | 11 |